London, England, United Kingdom, January 26, 2026 — MyARC, a platform enabling fitness creators to train their communities at scale, today unveiled its next-generation platform designed to support, monetise, and grow creator-led fitness businesses worldwide.… Read More »MyARC Unveils Platform to Empower and Monetise Fitness Creators Worldwide
New York, United States, January 26, 2026 — Ace Therapeutics recently underscored its commitment to advancing chronic kidney disease (CKD) therapeutic development by offering one-stop CKD contract research services with a robust portfolio of validated… Read More »Ace Therapeutics Expands Access to Cutting-Edge CKD Contract Research Services with Validated Animal Models for Renal Drug Development
PALO ALTO, Calif., Jan. 26, 2026 /PRNewswire/ — In December 2025, KnowMade, a globally renowned intellectual property (IP) research firm under Yole Group, released its LiDAR for Automotive Patent Landscape Analysis 2025, recognizing Hesai as… Read More »Hesai Ranks No.1 in the World for Lidar Patents by KnowMade
SAN FRANCISCO, Jan. 26, 2026 /PRNewswire/ — Atlas Cup, the first professional sport to operate in space, today announces its inaugural championship to be held in 2028. Founded in late 2025, Atlas Cup is a… Read More »Atlas Cup launches world’s first professional orbital sport, inaugural championship races to be held in Low Earth Orbit in 2028
NEW YORK, Jan. 26, 2026 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading… Read More »NYSE Content Advisory: Pre-Market update + ICE Data Projects Coldest Stretch for U.S. in Decades
Creative Diagnostics launches specialized Rabbit Papilloma Model services for scientists. New York, NY, United States, January 26, 2026 — As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud… Read More »Creative Diagnostics Announces Rabbit Papilloma Model Services to Accelerate HPV-Related Antiviral and Oncology Research